Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables RefundsShares IssuedShares OutstandingShares OutstandingShares RepurchasedShort-Term Debt issuancesShort-Term Debt repaymentsWages, Salaries and Other
Ratios

Nutex Health (NUTX) Receivables - Other (2016 - 2023)

Nutex Health (NUTX) has disclosed Receivables - Other for 5 consecutive years, with $538259.0 as the latest value for Q1 2023.

  • For Q1 2023, Receivables - Other changed N/A year-over-year to $538259.0; the TTM value through Mar 2023 reached $538259.0, changed N/A, while the annual FY2022 figure was $538184.0, 58.23% down from the prior year.
  • Receivables - Other hit $538259.0 in Q1 2023 for Nutex Health, roughly flat from $538184.0 in the prior quarter.
  • Across five years, Receivables - Other topped out at $6.7 million in Q3 2021 and bottomed at $538184.0 in Q4 2022.
  • Average Receivables - Other over 3 years is $2.0 million, with a median of $1.3 million recorded in 2021.
  • On a YoY basis, Receivables - Other climbed as much as 58.23% in 2022 and fell as far as 74.7% in 2022.
  • Nutex Health's Receivables - Other stood at $1.3 million in 2021, then crashed by 58.23% to $538184.0 in 2022, then rose by 0.01% to $538259.0 in 2023.
  • According to Business Quant data, Receivables - Other over the past three periods came in at $538259.0, $538184.0, and $1.7 million for Q1 2023, Q4 2022, and Q3 2022 respectively.